Brand-Backed ASBM Pushes Back On Biosimilar Reforms
Association Questions FDA Findings On Switching And Interchangeability
Brand-backed association the Alliance for Safe Biologic Medicines has expressed caution over FDA findings that bolster the case for biosimilar switching and suggest a reduction in the need for switching studies to support interchangeability.
